The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Contract Development Manufacturing Organizations Market Over The Period 2026–2030?
The contract development manufacturing organizations market size has experienced swift expansion over recent years. It is anticipated to increase from $274.79 billion in 2025 to $309.9 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.8%. The historical growth of this market can be attributed to elements such as cost optimization through outsourcing, rising r&d expenditure in pharmaceuticals, growing generic drug production, increasing regulatory complexity, and limited in-house manufacturing capacity.
The contract development manufacturing organizations market is anticipated to undergo significant expansion in the coming years. It is forecast to achieve a valuation of $503.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.9%. This projected growth throughout the forecast period stems from the advancement of biologics and advanced therapies, an increasing need for flexible manufacturing capabilities, the expansion of small and mid-size pharmaceutical companies, heightened clinical trial activity, and the global proliferation of pharmaceutical pipelines. Prominent trends for this period include a rise in outsourcing for drug development and manufacturing, a growing demand for integrated cdmo services, an increase in the production of biologics and biosimilars, a greater emphasis on regulatory compliance and quality assurance, and the expansion of capacity in emerging pharmaceutical markets.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3885&type=smp
Which Economic Or Industry Drivers Are Impacting The Contract Development Manufacturing Organizations Market?
The expanding demand for pharmaceutical goods, stemming from the rise in chronic diseases and the increasing geriatric population, has fueled the growth of the contract development manufacturing organizations market. The escalating prevalence of chronic illnesses and the aging demographic have enabled pharmaceutical companies to accelerate the production of biologics and biosimilars. In response, most pharmaceutical firms have engaged contract production and manufacturing organizations, operating on a contractual basis, to manage and coordinate their company’s tasks, operations, and tests. For instance, in November 2023, as per the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based, trade association, the total pharmaceutical production in Europe was valued at €390,000 million ($422,803 million) in 2023, marking an increase from €363,300 million ($393,857 million) in 2022. Consequently, the increasing need for pharmaceutical products is a key factor propelling the expansion of the contract development manufacturing organizations market.
How Is The Contract Development Manufacturing Organizations Market Divided Into Its Major Segments?
The contract development manufacturing organizations market covered in this report is segmented –
1) By Service: CMO, CRO
2) By Product: Small Molecules, Biologics
3) By End User: Big Pharma, Small and Mid-size Pharma, Generic Pharmaceutical Companies, Other End Users
Subsegments:
1) By CMO (Contract Manufacturing Organization): API (Active Pharmaceutical Ingredient) Manufacturing, Formulation Development, Finished Product Manufacturing, Packaging Services
2) By CRO (Contract Research Organization): Preclinical Research Services, Clinical Trial Management, Data Management And Biostatistics, Regulatory Affairs Consulting
How Are Trends Transforming The Contract Development Manufacturing Organizations Market Landscape?
Major companies operating in the contract development and manufacturing organizations market are concentrating on innovative developments, such as Lifera, to boost revenues in their sector. Lifera is structured as a commercial-scale contract development and manufacturing organization (CDMO). For instance, in June 2023, Lifera was launched by the Public Investment Fund (PIF), Saudi Arabia’s global investment organization. Lifera’s main focus will be the production of vital biopharmaceutical goods, including insulin, vaccinations, monoclonal antibodies, plasma treatments, cell and gene therapies, and cutting-edge small chemicals. To expand local capacity and support domestic manufacturing in this industry, the corporation also intends to form alliances with top domestic and foreign businesses and attract specific investments. Among Lifera’s objectives are driving formulation development, medication development, and manufacturing.
Who Are The Prominent Organizations Shaping The Contract Development Manufacturing Organizations Market?
Major companies operating in the contract development manufacturing organizations market are Recipharm AB, AbbVie Contract Manufacturing LLC, Almac Group Limited, Baxter BioPharma Solutions LLC, Boehringer Ingelheim International GmbH, Catalent Pharma Solutions Inc., CMIC Holdings Co. Ltd., Covance Inc., Evotec SE, Famar Health Care Services Madrid SA, Jubilant Life Sciences Limited, Lonza Group Ltd., Patheon UK Limited, Pfizer CentreOne, Thermo Fisher Scientific Inc., Vetter Pharma International GmbH, Advanced BioScience Laboratories Inc., Adare Pharmaceuticals Inc., Aenova Holding GmbH, Ajinomoto Bio-Pharma Services, Albany Molecular Research Inc., Cambrex Corporation, CordenPharma International GmbH, EirGen Pharma Limited, Grand River Aseptic Manufacturing, Hovione LLC, Metrics Contract Services, NextPharma Technologies Holding Limited, Nitto Avecia Pharma Services Inc., Piramal Pharma Solutions Inc., Siegfried Holding AG, Therapure Biopharma Inc., Velesco Pharmaceutical Services, WuXi PharmaTech (Cayman) Inc.
Read the full contract development manufacturing organizations market report here:
What Are The Top-Performing Regions Within The Contract Development Manufacturing Organizations Market?
North America was the largest region in contract development manufacturing organizations market in 2025. The regions covered in the contract development manufacturing organizations market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Contract Development Manufacturing Organizations Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3885&type=smp
Browse Through More Reports Similar to the Global Contract Development Manufacturing Organizations Market 2026, By The Business Research Company
Contract Development Manufacturing Organizations Market Report 2026
Contract Research And Manufacturing Services Market Report 2026
Electronic Contract Manufacturing And Design Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model